Dubai’s new longevity policy prompts a look at how a regulator-led strategy could shape a budding longevity healthcare and innovation hub.
Key Takeaways
- Dubai established a dedicated longevity authority to create regulatory clarity for the sector
- AEON Clinic publicly endorsed the authority and plans to align personalized longevity services with its framework
- Dubai's D33 economic agenda is directing investment and policy toward healthcare and biotechnology development